Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Accumulated Expenses (2016 - 2020)

Historic Accumulated Expenses for Trinity Biotech (TRIB) over the last 6 years, with Q4 2020 value amounting to $8.8 million.

  • Trinity Biotech's Accumulated Expenses rose 881.59% to $8.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was $8.8 million, marking a year-over-year increase of 881.59%. This contributed to the annual value of $8.8 million for FY2020, which is 881.59% up from last year.
  • Latest data reveals that Trinity Biotech reported Accumulated Expenses of $8.8 million as of Q4 2020, which was up 881.59% from $8.1 million recorded in Q4 2019.
  • Over the past 5 years, Trinity Biotech's Accumulated Expenses peaked at $11.6 million during Q4 2017, and registered a low of $7.9 million during Q4 2018.
  • In the last 5 years, Trinity Biotech's Accumulated Expenses had a median value of $8.8 million in 2020 and averaged $9.5 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 1743.68% in 2016, then crashed by 3219.14% in 2018.
  • Over the past 5 years, Trinity Biotech's Accumulated Expenses (Quarter) stood at $10.9 million in 2016, then rose by 6.81% to $11.6 million in 2017, then crashed by 32.19% to $7.9 million in 2018, then increased by 3.24% to $8.1 million in 2019, then grew by 8.82% to $8.8 million in 2020.
  • Its Accumulated Expenses was $8.8 million in Q4 2020, compared to $8.1 million in Q4 2019 and $7.9 million in Q4 2018.